AIVIVO pioneers a new drug discovery paradigm with the Organome Platform, capturing the dynamic effect of diseases and treatments at organ and organ systems level for the first time. The platform has 3 main components:
Proprietary in-silico organ level models, mapping cellular dynamic behaviour changes at organ and organ systems levels. OrganoMaps
Proprietary validated prediction engine to identify novel mechanisms and treatment strategies to modulate disease at organ level. Proprietary Design Studio that seamlessly integrates OrganoMaps and molecular design algorithms to develop novel assets with higher chance of clinical success.
AI VIVO Perdition Engine empowered by GPU clusters and proprietary search algorithms to explore all OrganoMaps and predict and rank unexpected mechanisms and multi modal modulators to treat a disease at organ level.